Like ex parte re-examination
, inter partes review can only be used for an anticipatory challenge based on patents or printed publications.
If the vehicle doesn't qualify for a re-test but is brought back to the testing station within 10 days, only a partial re-examination
is required and a maximum of half the full fee can be charged.
Today, on the 20th anniversary of Christopher's disappearance, detectives will begin a re-examination
of the case.
Although the contents of the re-examination
are not necessarily clear, it appears that the party intends to encourage local communities to discuss whether to go back to a six-day school week or keep the current five-day framework-leaving the final decision to the communities themselves.
is the process by which patent owners or other parties send an issued patent back to the United States Patent and Trademark Office to be re-evaluated to determine if it meets the required standards of patentability.
request cites extensive evidence of the prior existence of yellow beans with traits identical to the enola patent, and it accuses Proctor or bringing the beans into the country illegally.
of the role of the Newsletter Publishers Assn.
Through careful re-examination
of documentary evidence and more recent scholarly speculation that has been more widely accepted than convincing, Harley also questions the usual assumption that Byrd married twice.
They make this compact volume, a pastiche of previously published articles and speeches stitched together with new commentary, a valuable and lively re-examination
of issues that are both fundamental and very much alive today.
Health Discovery Corporation (OTCBB: HDVY) has received notification from the United States Patent and Trademark Office that it intends to issue a re-examination
certificate to Intel Corporation following completion of the re-examination
of Intel's Patent No.
PTC intends to request a re-examination
of the CHMP opinion with a final outcome expected in the second quarter of 2014, when the confirmatory study is expected to be more fully enrolled.
Melbourne, Australia, Nov 8, 2010 - (ABN Newswire) - Benitec Limited (ASX:BLT) (PINK:BNIKF), the , the leading company in expressed gene silencing for human therapeutics, announced today that the United States Patent and Trademark Office (USPTO) has issued an official Notice of Intent to Issue an Ex Parte Re-examination
Certificate for US Patent 6,573,099 ("the '099 Graham Patent"), the wide-ranging platform technology patent covering the use of expressed RNAi in human therapeutic applications.